This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert J. G. Chalmers, MRCP; Sam Shuster, PhD, FRCP
The Skin Hospital Quay Street Manchester M3 3HL, England

Arch Dermatol. 1984;120(6):707-708.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In the July ARCHIVES Zackheim reported¹ that human growth hormone failed to influence the course of dominant dystrophic epidermolysis bullosa (DDEB) in two children given eight-week courses of human growth hormone injections. We similarly failed to demonstrate any beneficial effect from a six-month course of human growth hormone injections given to an adult with DDEB.

Report of a Case.—

A 47-year-old woman had suffered from recurrent blistering and scarring of the skin since infancy. Her father and her son were similarly affected. Examination showed atrophy and scarring, mostly affecting the extensor aspects of the arms, the dorsa of the hands and the fingers, with loss of several fingernails. There were variably sized hemorrhagic bullae, erosions, and crusts within the scarred areas. Similar but less severe changes were present on the lower limbs, especially around the knees and on the fronts of the shins. There was no . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?